FindTrial
Sign In

Study on characteristics of circulating MG53 level in different population and the effect of exercise on it

Study on characteristics of circulating MG53 level in different population and the effect of exercise on it

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052983
Enrollment
Unknown
Registered
2021-11-07
Start date
2018-10-10
Completion date
Unknown
Last updated
2022-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic metabolic diseases

Interventions

Common people:Nil
Physically active:Nil
athletes:Nil
High-intensity intermittent exercise:exercise
Endurance exercise:exercise
exhaustive running:exercise
exhaustive riding :exercise
metabolism disease:Nil

Sponsors

National Research Institute of Sports Medicine, General Administration of Sport of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 79 Years

Inclusion criteria

Inclusion criteria: Trial 1: People with chronic diseases, athletes, fitness person, healthy volunteers. Trial 2: (1) Healthy men aged 18-30 who have exercise habits; (2) Professionally trained road cyclists.

Exclusion criteria

Exclusion criteria: Trial 1: people suffering from two or more diseases; Trial 2: People with cardiovascular and cerebrovascular diseases, metabolic diseases (hypertension, diabetes, dyslipidemia, etc.), sports injuries, and those who were unable to complete two acute trials.

Design outcomes

Primary

MeasureTime frame
MG53;Triglyceride;High density lipoprotein, HDLC;Total cholesterol, TC;testosterone;Creatine kinase, CK;Blood urea nitrogen, BUN;VO2max;—

Countries

China

Contacts

Public ContactYi Muqing
Muqingyi@163.com+86 13911993819

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026